Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.49% | $215.09M | €456.01B | 69.49% | 76 Outperform | |
| Roche Holding AG | 1.45% | $124.90M | CHF284.70B | 44.00% | 73 Outperform | |
| HSBC Holdings | 1.39% | $119.82M | £224.27B | 52.25% | 80 Outperform | |
| Novartis AG | 1.33% | $115.06M | CHF228.31B | 23.99% | 80 Outperform | |
| AstraZeneca | 1.32% | $113.78M | $299.27B | 27.68% | 80 Outperform | |
| Nestlé SA | 1.18% | $101.61M | CHF199.53B | 21.38% | 71 Outperform | |
| Siemens | 1.03% | $89.29M | €195.46B | 22.39% | 74 Outperform | |
| Toyota Motor | 1.01% | $87.39M | ¥49.27T | 31.98% | 80 Outperform | |
| Shell (UK) | 1.00% | $86.24M | £157.08B | 6.95% | 73 Outperform | |
| Mitsubishi UFJ Financial Group | 0.97% | $83.89M | ¥33.00T | 55.28% | 76 Outperform |